Company Filing History:
Years Active: 2019
Title: Theodor Zweifel: Innovator in Pharmaceutical Synthesis
Introduction
Theodor Zweifel is a notable inventor based in Zug, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, specifically through his innovative methods of synthesizing important compounds.
Latest Patents
Zweifel holds a patent related to the "Synthesis of copanlisib and its dihydrochloride salt." This invention outlines a novel method for preparing copanlisib, copanlisib dihydrochloride, and their hydrates. The patent also introduces novel intermediate compounds that facilitate the preparation of copanlisib and its derivatives, showcasing the importance of his work in the development of cancer therapeutics.
Career Highlights
Currently, Theodor Zweifel is associated with Bayer Pharma Aktiengesellschaft, where he utilizes his expertise in pharmaceutical research and development. His career has been marked by a strong focus on innovative strategies that advance drug production and efficacy.
Collaborations
Throughout his career, Zweifel has collaborated with several talented professionals, including Jan-Georg Peters and Philipp Rubenbauer. These partnerships highlight the collaborative nature of scientific research and innovation within the pharmaceutical industry.
Conclusion
Theodor Zweifel's contributions to the field of pharmaceutical synthesis, particularly his patent on copanlisib, demonstrate his commitment to advancing medical science. His work not only adds valuable knowledge to the industry but also potentially improves treatment options for patients in need.